Tadalafil attenuates ischemic damage as well as reperfusion injury in the rat ovary

被引:3
作者
Sahin, Cagdas [1 ]
Yildirim, Nuri [1 ]
Akdemir, Ali [1 ]
Ozsener, Serdar [1 ]
Yigitturk, Gurkan [2 ]
Erbas, Oytun [3 ]
机构
[1] Ege Univ, Dept Obstet & Gynecol, Fac Med, Izmir, Turkey
[2] Mugla Sitki Kocman Univ, Dept Histol & Embryol, Fac Med, Mugla, Turkey
[3] Demiroglu Bilim Univ, Dept Physiol, Fac Med, Istanbul, Turkey
关键词
Phosphodiesterase type-5; tadalafil; ischemia-reperfusion injury; vasodilatation; anti-oxidant; ISCHEMIA/REPERFUSION INJURY; PHOSPHODIESTERASE-5; INHIBITOR; ERECTILE DYSFUNCTION; ADNEXAL TORSION; EFFICACY;
D O I
10.4274/jtgga.galenos.2019.2018.0121
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Tadalafil is a selective phosphodiesterase type-5 inhibitor with a long half-life. It has a dual function in ischaemic and re-perfused tissues, i.e. vasodilatation and anti-oxidant effects. These features of tadalafil distinguish it from other anti-oxidants. We investigated the dual effect of tadalafil on ischaemia and reperfusion injury in the rat ovary. Material and Methods: We established five study groups. Group 1 (n=6): sham-operated; group 2 (n=6): torsion; group 3 (n=6): torsion and Tadalafil; group 4 (n=6): torsion/de-torsion; and group 5 (n=6): torsion/de-torsion and tadalafil. Ovarian samples were harvested from animals and evaluated in terms of histopathologic changes, tissue malondialdehyde (MDA) concentrations, lactate production, and plasma cyclic guanosine monophosphate (cGMP). Results: Follicular degeneration, oedema, haemorrhage, and inflammatory cells were significantly decreased in group 5 in comparison with group 4. Group 2 and group 3 were compared in terms of vascular congestion and haemorrhage; these parameters were significantly decreased in group 3. In addition, significantly decreased MDA and lactate concentrations were observed in group 5 in comparison with group 4. Increased cGMP concentrations were detected in group 3 and group 5. Conclusion: We conclude that tadalafil might be useful in protecting the ovary against ischaemia and reperfusion injury. In the evet of ovarian torsion, it will provide a greater therapeutic effect than only performing de-torsion of the ovary or using other anti-oxidant agents.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 25 条
[1]   Long-acting phosphodiesterase-5 inhibitor, tadalafil, induces sustained cardioprotection against lethal ischemic injury [J].
Ahmad, Nauman ;
Wang, Yigang ;
Ali, Ailia K. ;
Ashraf, Muhammad .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2009, 297 (01) :H387-H391
[2]   Is ursodeoxycholic acid crucial for ischemia/reperfusion-induced ovarian injury in rat ovary? [J].
Akdemir, Ali ;
Sahin, Cagdas ;
Erbas, Oytun ;
Yeniel, Ahmet O. ;
Sendag, Fatih .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (02) :445-450
[3]   Effects of tadalafil on ischemia/reperfusion injury in rat brain [J].
Altas, Murat ;
Aras, M. ;
Meydan, S. ;
Nacar, E. ;
Ulutas, K. T. ;
Serarslan, Y. ;
Yilmaz, N. .
ACTA NEUROLOGICA BELGICA, 2014, 114 (01) :33-40
[4]   Protective effect of tadalafil on ischemia/reperfusion injury of rat ovary [J].
Arikan, Deniz Cemgil ;
Bakan, Vedat ;
Kurutas, Ergul Belge ;
Sayar, Hamide ;
Coskun, Ayhan .
JOURNAL OF PEDIATRIC SURGERY, 2010, 45 (11) :2203-2209
[5]   ADNEXAL TORSION - CAN THE ADNEXA BE SAVED [J].
BAYER, AI ;
WISKIND, AK .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (06) :1506-1511
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]  
Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO
[8]  
2-6
[9]   Sildenafil Reduces Ischemia-Reperfusion Injury in Rat Ovary: Biochemical and Histopathological Evaluation [J].
Celik, Muhamnnet ;
Aksoy, Ayse Nur ;
Aksoy, Hulya ;
Aksoy, Yilmaz ;
Halici, Zekai .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2014, 78 (03) :162-167
[10]   The discovery of tadalafil:: A novel and highly selective PDE5 inhibitor.: 2:: 2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione analogues [J].
Daugan, A ;
Grondin, P ;
Ruault, C ;
de Gouville, ACL ;
Coste, H ;
Linget, JM ;
Kirilovsky, J ;
Hyafil, F ;
Labaudinière, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (21) :4533-4542